Vinge advised EQT X on the deal. EQT X, through its indirectly owned subsidiary Oak BidCo S.à r.l., secured an ownership of 72.5% of the votes...
You must be a Standard 1 Year member to access this content.
Vinge advised EQT AB on the deal. EQT secured a EUR 1.5 billion sustainability-linked revolving credit facility.The sustainability-linked credit facility has a tenor of 5 years...
You must be a Standard 1 Year member to access this content.
Vinge advised Ambea AB on the deal. Ambea AB (publ) entered into an unsecured sustainability-linked facility agreement with a bank syndicate comprised of three Nordic banks....
You must be a Standard 1 Year member to access this content.
Vinge has advised Advent International on the deal. Plesner acted as lead counsel for Marlin Equity Partners on the transaction. Advent International, one of the largest...
You must be a Standard 1 Year member to access this content.
Vinge advised Vimian and the principal shareholder Fidelio. Vimian Group AB announced the listing of and commencement of trading in its ordinary shares on Nasdaq First North...
You must be a Standard 1 Year member to access this content.
Vinge advised Vimian and the principal shareholder Fidelio. Vimian Group AB announced the listing of and commencement of trading in its ordinary shares on Nasdaq First North...
You must be a Standard 1 Year member to access this content.
Vinge advised Destiny on the deal. Roschier advised SEB Private Equity and the other shareholders in the transaction. SEB Private Equity has sold Sweden-based UCaaS platform...
You must be a Standard 1 Year member to access this content.
Vinge advised Atlas Antibodies AB on the deal. Atlas Antibodies AB has signed an agreement to acquire UK company HistoCyte Laboratories Ltd. HistoCyte Laboratories’ portfolio of...
You must be a Standard 1 Year member to access this content.
